Vanessa Broadhurst Johnson & Johnson (JNJ) insider trading activity

Vanessa Broadhurst is EVP, Global Corp Affairs of JOHNSON & JOHNSON. Currently has a direct ownership of 21,681 shares of JNJ, which is worth approximately $3.52 Million. The most recent transaction as insider was on Feb 18, 2025, when has been sold 158 shares (Common Stock) at a price of $156.15 per share, resulting in proceeds of $24,671. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.7K

9.31% 3M change

9.41% 12M change

Total Value Held $3.52 Million

Vanessa Broadhurst Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2025	SELL Payment of exercise price or tax liability	$24,671 $156.15 p/Share	158 Reduced 0.72%	21,681 Common Stock
Feb 15 2025	BUY Exercise of conversion of derivative security	-	492 Added 2.2%	21,839 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$269,028 $156.23 p/Share	1,722 Reduced 6.8%	23,594 Common Stock
Feb 14 2025	BUY Exercise of conversion of derivative security	-	4,740 Added 16.16%	24,591 Common Stock
Feb 13 2025	BUY Exercise of conversion of derivative security	-	408 Added 1.98%	20,242 Common Stock
Jul 08 2024	SELL Payment of exercise price or tax liability	$738,448 $147.16 p/Share	5,018 Reduced 20.19%	19,834 Common Stock
Jul 08 2024	BUY Exercise of conversion of derivative security	-	9,809 Added 28.3%	24,852 Common Stock
Mar 13 2024	SELL Open market or private sale	$1,441,764 $162.16 p/Share	8,891 Reduced 37.15%	15,043 Common Stock
Feb 13 2024	SELL Payment of exercise price or tax liability	$32,990 $157.85 p/Share	209 Reduced 0.87%	23,934 Common Stock
Feb 13 2024	BUY Exercise of conversion of derivative security	-	408 Added 1.66%	24,143 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$336,206 $157.4 p/Share	2,136 Reduced 8.26%	23,735 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	790 Added 2.96%	25,871 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	-	4,701 Added 15.78%	25,081 Common Stock
Feb 08 2024	SELL Payment of exercise price or tax liability	$109,899 $156.33 p/Share	703 Reduced 3.33%	20,380 Common Stock
Feb 08 2024	BUY Exercise of conversion of derivative security	-	1,880 Added 8.19%	21,083 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$233,294 $162.01 p/Share	1,440 Reduced 6.98%	19,203 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	3,981 Added 16.17%	20,643 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$96,761 $162.08 p/Share	597 Reduced 3.46%	16,662 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	-	1,592 Added 8.45%	17,259 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$153,448 $165.89 p/Share	925 Reduced 5.57%	15,667 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	2,557 Added 13.35%	16,592 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$152,303 $168.85 p/Share	902 Reduced 6.04%	14,035 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	-	2,451 Added 14.1%	14,937 Common Stock

Also insider at

ZTS

Zoetis Inc. Healthcare

Director